JPS6346723B2 - - Google Patents

Info

Publication number
JPS6346723B2
JPS6346723B2 JP54123198A JP12319879A JPS6346723B2 JP S6346723 B2 JPS6346723 B2 JP S6346723B2 JP 54123198 A JP54123198 A JP 54123198A JP 12319879 A JP12319879 A JP 12319879A JP S6346723 B2 JPS6346723 B2 JP S6346723B2
Authority
JP
Japan
Prior art keywords
physiologically active
active substance
weight
parts
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54123198A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5646807A (en
Inventor
Isao Kaetsu
Masaru Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Atomic Energy Agency
Original Assignee
Japan Atomic Energy Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Atomic Energy Research Institute filed Critical Japan Atomic Energy Research Institute
Priority to JP12319879A priority Critical patent/JPS5646807A/ja
Priority to US06/188,812 priority patent/US4379038A/en
Priority to DE3036449A priority patent/DE3036449C2/de
Publication of JPS5646807A publication Critical patent/JPS5646807A/ja
Publication of JPS6346723B2 publication Critical patent/JPS6346723B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/44—Polymerisation in the presence of compounding ingredients, e.g. plasticisers, dyestuffs, fillers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/46—Polymerisation initiated by wave energy or particle radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP12319879A 1979-09-27 1979-09-27 Production of composition of complex gradually releasing physiologically active substance Granted JPS5646807A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP12319879A JPS5646807A (en) 1979-09-27 1979-09-27 Production of composition of complex gradually releasing physiologically active substance
US06/188,812 US4379038A (en) 1979-09-27 1980-09-19 Process for preparing a physiologically active substance controlled release composite composition
DE3036449A DE3036449C2 (de) 1979-09-27 1980-09-26 Verfahren zur Herstellung einer eine physiologisch aktive Substanz enthaltenden Zusammensetzung mit kontrollierter Wirkstoffreigabe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12319879A JPS5646807A (en) 1979-09-27 1979-09-27 Production of composition of complex gradually releasing physiologically active substance

Publications (2)

Publication Number Publication Date
JPS5646807A JPS5646807A (en) 1981-04-28
JPS6346723B2 true JPS6346723B2 (enExample) 1988-09-19

Family

ID=14854615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12319879A Granted JPS5646807A (en) 1979-09-27 1979-09-27 Production of composition of complex gradually releasing physiologically active substance

Country Status (3)

Country Link
US (1) US4379038A (enExample)
JP (1) JPS5646807A (enExample)
DE (1) DE3036449C2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020194723A1 (ja) * 2019-03-28 2020-10-01 堺ディスプレイプロダクト株式会社 表示装置、及び、表示装置の取り付け構造

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58113102A (ja) * 1981-12-26 1983-07-05 Earth Chem Corp Ltd 薬剤の徐放化材
EP0097864B1 (de) * 1982-06-21 1986-11-12 Hoechst Aktiengesellschaft Photopolymerisierbares Gemisch und damit hergestelltes photopolymerisierbares Kopiermaterial
US4652443A (en) * 1983-06-07 1987-03-24 Japan Atomic Energy Research Institute Slow-release composite and process for producing the same
NL8401362A (nl) * 1984-04-27 1985-11-18 Tno Werkwijze voor het met een polymeer omhullen van deeltjesvormige materialen teneinde de gereguleerde afgifte van deze materialen aan de omgeving mogelijk te maken alsmede aldus verkregen omhuld deeltjesvormig materiaal.
JPS6245537A (ja) * 1985-08-23 1987-02-27 Sumitomo Electric Ind Ltd 医用樹脂組成物及びその製造方法
US5034428A (en) * 1986-06-19 1991-07-23 Board Of Regents Of The University Of Washington Immobilized biomolecules and method of making same
US4829098A (en) * 1986-06-19 1989-05-09 Washington Research Foundation Immobilized biomolecules and method of making same
CA2028804C (en) * 1989-11-21 2000-06-20 Howard J. Buttery Biomosaic polymers and method for preparing same
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
JP3153135B2 (ja) 1996-10-15 2001-04-03 三洋化成工業株式会社 抗菌性吸水剤組成物およびその製造法
KR101053558B1 (ko) 2004-03-30 2011-08-03 유로-셀띠끄 소시에떼 아노님 흡착제 및 억제제를 포함하는 내변조성 제형

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US3767790A (en) * 1972-02-11 1973-10-23 Nat Patent Dev Corp Microorganisms
GB1439132A (en) * 1972-03-13 1976-06-09 Special Polymers Ltd Method for the production of a hydrophilic polymer product
US3901966A (en) * 1973-09-10 1975-08-26 Union Corp Sustained release of methantheline
US3900559A (en) * 1973-09-10 1975-08-19 Union Corp Sustained release of methantheline
US3901968A (en) * 1973-09-10 1975-08-26 Union Corp Sustained release of methantheline
US4025391A (en) * 1974-06-15 1977-05-24 Director Of National Food Research Institute Preparation of bead-shaped immobilized enzyme
JPS5231981A (en) * 1975-08-18 1977-03-10 Takeda Chem Ind Ltd Microcapsule preparation method
US4218437A (en) * 1976-07-23 1980-08-19 Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) Animal feeds containing a mixture of virginiamycin, zinc bacitracin or flavophospholipol and proteolytic enzymes
JPS53146411A (en) 1977-05-27 1978-12-20 Nat Jutaku Kenzai Method of reinforcing foundation
CA1125698A (en) * 1978-03-09 1982-06-15 Masaru Yoshida Process for preparing a polymer composition
US4144327A (en) * 1978-03-20 1979-03-13 G. D. Searle & Co. Antimicrobial composition comprising lytic enzymes from physarum and an antimycotic agent
JPS5585516A (en) * 1978-11-27 1980-06-27 Japan Atom Energy Res Inst Method of preparing polymer composition containing carcinostatic substance
JPS55110105A (en) * 1979-02-19 1980-08-25 Japan Atom Energy Res Inst Preparation of polymer composition containing physiologically active material

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020194723A1 (ja) * 2019-03-28 2020-10-01 堺ディスプレイプロダクト株式会社 表示装置、及び、表示装置の取り付け構造

Also Published As

Publication number Publication date
US4379038A (en) 1983-04-05
JPS5646807A (en) 1981-04-28
DE3036449A1 (de) 1981-04-16
DE3036449C2 (de) 1984-09-06

Similar Documents

Publication Publication Date Title
US4321117A (en) Process for preparing a polymer composition
US4359483A (en) Process for producing a multi-layered slow release composite
CA1288344C (en) Drug delivery system
JP2535339B2 (ja) 活性物質の制御速度制御用装置
US5015479A (en) Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine
JP2784184B2 (ja) スフェロイド
US5057317A (en) Slow-release pharmaceutical agent
DE60021059T2 (de) Partikuläre pharmazeutische Zusammensetzung für eine transdermale Partikelabgabe aus einem nadellosen Spritzensystem
JP3286315B2 (ja) 可溶性活性物質の調節された放出のための組成物及び方法
JPS6346723B2 (enExample)
CA1288049C (en) Sustained release capsule or tablet formulation
EP0052076B1 (de) Schnellzerfallende Arzneimittel-Presslinge
LU85817A1 (de) Lagerstabile,schnellzerfallende pharmazeutische wirkstoff-presslinge
JPS63258406A (ja) 持続放出製剤
JPH02104A (ja) 薬物放出速度調節型製剤
US4310397A (en) Polymer composition containing a physiologically active substance
JPS63165318A (ja) 光の影響に対して安定化したニフェディピン濃縮物及びその製造方法
US4267138A (en) Coating ensuring a controlled release of active ingredients of biologically active compositions, particularly pharmaceutical compositions and a process for preparation of biologically active compositions ensuring controlled release of active ingredients
US4632828A (en) Pharmaceutical composition
US20060039997A1 (en) Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
US3920806A (en) Growth promoting subcutaneous compositions
JPS6059204B2 (ja) 徐放性複合体の製造方法
CA2011682A1 (en) Method for preparing hydrogel preparations and exrogel preparations
JP2638604B2 (ja) 徐放性製剤
JPS588402B2 (ja) 重合体組成物の製造方法